CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis

Nature Communications

Volumn 6, Issue , 2015, Pages

  Huang, Qi Quan ^a   Perlman, Harris ^a   Birkett, Robert ^a   Doyle, Renee ^a   Fang, Deyu ^a   Haines, G Kenneth ^b   Robinson, William ^c   Datta, Syamal ^a   Huang, Zan ^d   Li, Quan Zhen ^e   Phee, Hyewon ^a   Pope, Richard M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WUHAN UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FLICE INHIBITORY PROTEIN; GLYCOPROTEIN P 15095;

ANTIBODY; DISEASE SEVERITY; HOMEOSTASIS; IMMUNE SYSTEM; OSTEOLOGY; PATHOLOGY; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PLASMABLAST; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; ANIMAL; ARTHRITIS; AUTOIMMUNE DISEASE; DENDRITIC CELL; FEMALE; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; ANTIGENS, CD11C; ARTHRITIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 84929224752     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8086     Document Type: Article

References (65)

1. Shortman, K. & Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30 (2007).
2. Ganguly, D., Haak, S., Sisirak, V. & Reizis, B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 13, 566-577 (2013).
3. Belz, G. T. & Nutt, S. L. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 12, 101-113 (2012).
4. Gallegos, A. M. & Bevan, M. J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200, 1039-1049 (2004).
5. Dresch, C. et al. Thymic but not splenic CD8(+) DCs can efficiently cross-prime T cells in the absence of licensing factors. Eur. J. Immunol. 41, 2544-2555 (2011).
6. Lei, Y. et al. Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development. J. Exp. Med. 208, 383-394 (2011).
7. Ohnmacht, C. et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206, 549-559 (2009).
8. Birnberg, T. et al. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 29, 986-997 (2008).
9. Coquet, J. M. et al. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway. J. Exp. Med. 210, 715-728 (2013).
10. Yamazaki, S. et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181, 6923-6933 (2008).
11. Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
12. Wildin, R. S., Smyk-Pearson, S. & Filipovich, A. H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39, 537-545 (2002).
13. Bar-On, L., Birnberg, T., Kim, K. W. & Jung, S. Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation. Eur. J. Immunol. 41, 291-298 (2011).
14. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014).
15. Ashany, D., Savir, A., Bhardwaj, N. & Elkon, K. B. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J. Immunol. 163, 5303-5311 (1999).
16. Willems, F. et al. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood 95, 3478-3482 (2000).
17. Stranges, P. B. et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26, 629-641 (2007).
18. Kamath, A. T. et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165, 6762-6770 (2000).
19. Huang, Q. Q. et al. FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis. Blood 116, 4968-4977 (2010).
20. Hubert, F. X. et al. Aire regulates the transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance. Blood 118, 2462-2472 (2011).
21. Jameson, S. C. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2, 547-556 (2002).
22. Waskow, C. et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9, 676-683 (2008).
23. Fujikado, N. et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 14, 176-180 (2008).
24. Hammer, G. E. et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat. Immunol. 12, 1184-1193 (2011).
25. Kool, M. et al. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35, 82-96 (2011).
26. Lamagna, C., Scapini, P., van Ziffle, J. A., DeFranco, A. L. & Lowell, C. A. Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proc. Natl Acad. Sci. USA 110, E3311-E3320 (2013).
27. Edelson, B. T. et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207, 823-836 (2010).
28. Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100 (2008).
29. Fukaya, T. et al. Conditional ablation of CD205+ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo. Proc. Natl Acad. Sci. USA 109, 11288-11293 (2012).
30. Luckashenak, N. et al. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28, 521-532 (2008).
31. Hanyecz, A. et al. Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis. Biomed. Res. Int. 2014, 942148 (2014).
32. de Jong, H. et al. Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 69, 255-262 (2010).
33. Alexopoulos, L. G., Youn, I., Bonaldo, P. & Guilak, F. Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix. Arthritis Rheum. 60, 771-779 (2009).
34. Manson, J. J. et al. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res. Ther. 11, R154 (2009).
35. Gueguen, P. et al. Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J. Clin. Immunol. 26, 495-505 (2006).
36. Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557-569 (2012).
37. Dresch, C., Leverrier, Y., Marvel, J. & Shortman, K. Development of antigen cross-presentation capacity in dendritic cells. Trends Immunol. 33, 381-388 (2012).
38. Paiva, R. S. et al. Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery. Proc. Natl Acad. Sci. USA 110, 6494-6499 (2013).
39. Idoyaga, J. et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123, 844-854 (2013).
40. Zlotoff, D. A. et al. CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus. Blood 115, 1897-1905 (2010).
41. Zhang, S. L. & Bhandoola, A. Trafficking to the thymus. Curr. Top. Microbiol. Immunol. 373, 87-111 (2014).
42. Hirota, K. et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J. Exp. Med. 204, 41-47 (2007).
43. Oh, S. et al. Requirement for diverse TCR specificities determines regulatory T cell activity in a mouse model of autoimmune arthritis. J. Immunol. 188, 4171-4180 (2012).
44. Martinez, R. J. et al. Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells. J. Immunol. 188, 170-181 (2012).
45. Jang, E. et al. Prevention of spontaneous arthritis by inhibiting homeostatic expansion of autoreactive CD4+ T cells in the K/BxN mouse model. Arthritis Rheum. 54, 492-498 (2006).
46. Symmons, D. P., Farr, M., Salmon, M. & Bacon, P. A. Lymphopenia in rheumatoid arthritis. J. R. Soc. Med. 82, 462-463 (1989).
47. Ponchel, F. et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood 100, 4550-4556 (2002).
48. Wing, K. & Sakaguchi, S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13 (2010).
49. Kelchtermans, H. et al. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann. Rheum. Dis. 68, 744-750 (2009).
50. Zaiss, M. M. et al. Regulatory T cells protect from local and systemic bone destruction in arthritis. J. Immunol. 184, 7238-7246 (2010).
51. Jang, E. et al. Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J. Immunol. 186, 1546-1553 (2011).
52. Wu, H. J. et al. Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J. Exp. Med. 204, 1911-1922 (2007).
53. Nadkarni, S., Mauri, C. & Ehrenstein, M. R. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med. 204, 33-39 (2007).
54. Kawashiri, S. Y. et al. CD4+CD25(high)CD127(low/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J. Rheumatol. 38, 2517-2521 (2011).
55. Wagner, U., Schatz, A., Baerwald, C. & Rossol, M. Brief report: deficient thymic output in rheumatoid arthritis despite abundance of prethymic progenitors. Arthritis Rheum. 65, 2567-2572 (2013).
56. Dehlin, M. et al. Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis. PLoS ONE 3, e3633 (2008).
57. Zwerina, J. et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum. 50, 277-290 (2004).
58. Huang, Q. Q. et al. Gp96 prpetuates the persistent inflammation of rheumatoid arthritis. Arthritis Rheum. 64, 3638-3648 (2012).
59. Huang, Q. Q. et al. Fas signaling in macrophages promotes chronicity in K/BxN serum-induced arthritis. Arthritis Rheumatol. 66, 68-77 (2014).
60. Huang, Q. Q. et al. TLR2 deletion promotes arthritis through reduction of IL-10. J. Leukoc. Biol. 93, 751-759 (2013).
61. Mountz, J. D. et al. Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand. J. Immunol. 61, 128-138 (2005).
62. Harre, U. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791-1802 (2012).
63. Robinson, W. H. et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21, 1033-1039 (2003).
64. Sathe, P. et al. The acquisition of antigen cross-presentation function by newly formed dendritic cells. J. Immunol. 186, 5184-5192 (2011).
65. Quah, B. J., Warren, H. S. & Parish, C. R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2, 2049-2056 (2007).